Before: Slow progress despite consistent training
The former is currently awaiting FDA approval for a handful of oral, daily GLP-1 agonists, while the latter is developing combination therapies that use their muscle-preserving antibodies, trevogrumab and garetosmab, alongside GLP-1 drugs like Wegovy and Ozempic, to improve fat loss while preserving muscle mass
doi: 10.1038/nm919 31 SalcedoITweedieDLiYGreigNH
Zwischen harten Sparringseinheiten, explosiven Kraftbelastungen und chronischer Beanspruchung von Gelenken, Sehnen und Muskulatur wchst deshalb das Interesse an sogenannten Recovery Peptides
Oct 15 2018;98(8):525-529
However, please note that metformins popularity among healthy-aging influencers who are young, lean, and non-diabetic is a separate issue